300595 欧普康视
已收盘 07-25 15:00:00
资讯
新帖
简况
欧普康视最新公告:控股子公司申报医疗器械注册证获得受理
证券之星 · 07-11
欧普康视最新公告:控股子公司申报医疗器械注册证获得受理
欧普康视:眼科相关的药品在共赢基础上争取销售权益
证券之星 · 07-11
欧普康视:眼科相关的药品在共赢基础上争取销售权益
欧普康视:截止到2025年7月10日股东总人数为63,178户
证券之星 · 07-11
欧普康视:截止到2025年7月10日股东总人数为63,178户
欧普康视新提交“欧普康视 OVCTEK”、“气特舒”等2件商标注册申请
证券之星 · 07-09
欧普康视新提交“欧普康视 OVCTEK”、“气特舒”等2件商标注册申请
欧普康视股价微涨0.97% 拟3.34亿元收购眼科医院资产
金融界 · 07-08
欧普康视股价微涨0.97% 拟3.34亿元收购眼科医院资产
【投融资动态】尚悦启程拟收购融资,融资额3.34亿人民币,投资方为欧普康视
证券之星 · 07-08
【投融资动态】尚悦启程拟收购融资,融资额3.34亿人民币,投资方为欧普康视
欧普康视:与雷神科技、汇鼎光学合作设立合资公司
证券之星 · 07-07
欧普康视:与雷神科技、汇鼎光学合作设立合资公司
【欧普康视:拟3.34亿元收购尚悦启程75%股权】 欧普康视7月4日公告,拟以3.34亿元收购宿迁市尚悦启程医院管理有限公司75%股权,其中拟使用募集资金2.34亿元,自有资金1亿元。本次收购完成后,尚悦启程将成为公司控股子公司并纳入合并财务报表范围。
金融界 · 07-04
【欧普康视:拟3.34亿元收购尚悦启程75%股权】 欧普康视7月4日公告,拟以3.34亿元收购宿迁市尚悦启程医院管理有限公司75%股权,其中拟使用募集资金2.34亿元,自有资金1亿元。本次收购完成后,尚悦启程将成为公司控股子公司并纳入合并财务报表范围。
欧普康视:巩膜镜可以矫正视力但无塑形角膜作用
证券之星 · 07-04
欧普康视:巩膜镜可以矫正视力但无塑形角膜作用
欧普康视:截止到2025年6月30日股东总人数为63,088户
证券之星 · 07-02
欧普康视:截止到2025年6月30日股东总人数为63,088户
欧普康视:江苏多姿医疗隐形眼镜已开始生产并接到少量订单
证券之星 · 07-02
欧普康视:江苏多姿医疗隐形眼镜已开始生产并接到少量订单
欧普康视(300595)6月20日股东户数6.3万户,较上期减少1.48%
证券之星 · 06-26
欧普康视(300595)6月20日股东户数6.3万户,较上期减少1.48%
【私募调研记录】祺顺投资调研欧普康视
证券之星 · 06-26
【私募调研记录】祺顺投资调研欧普康视
欧普康视:6月24日组织现场参观活动,中信证券、海富投资等多家机构参与
证券之星 · 06-25
欧普康视:6月24日组织现场参观活动,中信证券、海富投资等多家机构参与
欧普康视新提交2件商标注册申请
证券之星 · 06-23
欧普康视新提交2件商标注册申请
欧普康视:视光中心由视光技术人员提供专业服务
证券之星 · 06-18
欧普康视:视光中心由视光技术人员提供专业服务
欧普康视:公司将持续努力推动业务发展做好经营管理
证券之星 · 06-11
欧普康视:公司将持续努力推动业务发展做好经营管理
欧普康视:巩膜镜和塑形镜出口到海外要先取得当地药械管理部门的许可
证券之星 · 06-11
欧普康视:巩膜镜和塑形镜出口到海外要先取得当地药械管理部门的许可
欧普康视:已有一些签约,具体数据不便在互动易中披露
证券之星 · 06-10
欧普康视:已有一些签约,具体数据不便在互动易中披露
【投融资动态】博视医疗C轮融资,投资方为南京新工投资、欧普康视等
证券之星 · 06-07
【投融资动态】博视医疗C轮融资,投资方为南京新工投资、欧普康视等
加载更多
公司概况
公司名称:
欧普康视科技股份有限公司
所属行业:
专用设备制造业
上市日期:
2017-01-17
主营业务:
欧普康视科技股份有限公司的主营业务是眼视光产品及相关配套产品的研发、生产、销售,以及眼视光服务。公司的主要产品是硬性接触镜类、护理产品、硬镜以外的其它视光产品、其它眼健康产品。
发行价格:
23.81
{"stockData":{"symbol":"300595","market":"SZ","secType":"STK","nameCN":"欧普康视","latestPrice":17.98,"timestamp":1753427016000,"preClose":18.03,"halted":0,"volume":33221947,"delay":0,"changeRate":-0.0028,"floatShares":668000000,"shares":896000000,"eps":0.6021,"marketStatus":"已收盘","change":-0.05,"latestTime":"07-25 15:00:00","open":18.1,"high":18.55,"low":17.89,"amount":602000000,"amplitude":0.0366,"askPrice":17.99,"askSize":100,"bidPrice":17.98,"bidSize":235,"shortable":0,"etf":0,"ttmEps":0.6021,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753666200000},"marketStatusCode":5,"adr":0,"adjPreClose":18.03,"symbolType":"stock","openAndCloseTimeList":[[1753407000000,1753414200000],[1753419600000,1753426800000]],"highLimit":19.83,"lowLimit":16.23,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":896152386,"isCdr":false,"pbRate":3.33,"roa":"--","peRate":29.862149,"roe":"3.36%","epsLYR":0.6408,"committee":0.639956,"marketValue":16113000000,"turnoverRate":0.0497,"status":1,"floatMarketCap":12020000000},"requestUrl":"/m/hq/s/300595","defaultTab":"news","newsList":[{"id":"2550779938","title":"欧普康视最新公告:控股子公司申报医疗器械注册证获得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2550779938","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550779938?lang=zh_cn&edition=full","pubTime":"2025-07-11 16:58","pubTimestamp":1752224294,"startTime":"0","endTime":"0","summary":"欧普康视(300595.SZ)公告称,公司全资子公司欧普康视投资有限公司的控股子公司江苏多姿医疗科技有限公司申请的医疗器械产品“软性亲水接触镜”注册申请已获国家药品监督管理局受理,受理号为CQZ2501262。该产品为境内III类医疗器械,用于日戴矫正屈光不正。目前产品处于注册申请受理阶段,后续需通过技术审评才能获得注册证并投入生产、销售。该产品在国内外已有临床研究和使用,全球市场销售情况良好,国内已有同类产品上市。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071100027150.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1100","BK1574","BK1583","09997","300595","BK0251","BK1222","09996","159883"],"gpt_icon":0},{"id":"2550086980","title":"欧普康视:眼科相关的药品在共赢基础上争取销售权益","url":"https://stock-news.laohu8.com/highlight/detail?id=2550086980","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550086980?lang=zh_cn&edition=full","pubTime":"2025-07-11 16:48","pubTimestamp":1752223707,"startTime":"0","endTime":"0","summary":"证券之星消息,欧普康视(300595)07月11日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘,您好!上次提问中,公司回答公司参与了部分创新药企业的投资,并且参投企业在创新药方面取得了明显的成效!公司是否会在创新药营销方面与产投企业形成合作,包括在现有的渠道销售产品,或取得独家代理等!欧普康视回复:您好,上次互动易中提到的创新药品尚在研发阶段,还没有涉及营销。眼科相关的药品,在共赢的基础上,公司会争取销售方面的权益。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071100026693.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300595"],"gpt_icon":0},{"id":"2550980059","title":"欧普康视:截止到2025年7月10日股东总人数为63,178户","url":"https://stock-news.laohu8.com/highlight/detail?id=2550980059","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550980059?lang=zh_cn&edition=full","pubTime":"2025-07-11 16:48","pubTimestamp":1752223706,"startTime":"0","endTime":"0","summary":"证券之星消息,欧普康视(300595)07月11日在投资者关系平台上答复投资者关心的问题。投资者提问:截止七月十日股东人数?欧普康视回复:您好,截止到2025年7月10日,公司股东总人数为63,178户。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071100026688.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300595","BK0251"],"gpt_icon":0},{"id":"2550665192","title":"欧普康视新提交“欧普康视 OVCTEK”、“气特舒”等2件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2550665192","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550665192?lang=zh_cn&edition=full","pubTime":"2025-07-10 05:07","pubTimestamp":1752095239,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示,近日欧普康视科技股份有限公司新提交“欧普康视 OVCTEK”、“气特舒”等2件商标注册申请。商标申请详情如下:今年以来欧普康视科技股份有限公司新申请注册商标20件,截止目前公司共持有注册商标128件,另有70件商标尚在注册申请中。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071000003358.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300595"],"gpt_icon":0},{"id":"2550522218","title":"欧普康视股价微涨0.97% 拟3.34亿元收购眼科医院资产","url":"https://stock-news.laohu8.com/highlight/detail?id=2550522218","media":"金融界","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550522218?lang=zh_cn&edition=full","pubTime":"2025-07-09 01:41","pubTimestamp":1751996475,"startTime":"0","endTime":"0","summary":"截至2025年7月8日15时5分,欧普康视股价报15.54元,较前一交易日上涨0.15元,涨幅0.97%。当日开盘价为15.30元,最高触及15.59元,最低下探15.27元,成交量为78514手,成交金额达1.22亿元。欧普康视是一家专注于眼视光产品研发、生产及销售的企业,主要产品包括角膜塑形镜等硬性接触镜及配套护理产品。公司于7月4日晚间发布公告,拟以3.34亿元收购尚悦启程医院管理有限公司75%股权。此次收购评估增值率达771.49%,交易款项将分期支付,并设置了业绩承诺条款。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/09014151571413.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["300595","BK0251"],"gpt_icon":0},{"id":"2549490015","title":"【投融资动态】尚悦启程拟收购融资,融资额3.34亿人民币,投资方为欧普康视","url":"https://stock-news.laohu8.com/highlight/detail?id=2549490015","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549490015?lang=zh_cn&edition=full","pubTime":"2025-07-08 19:24","pubTimestamp":1751973857,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP于7月3日公布的信息整理,宿迁市尚悦启程医院管理有限公司拟收购融资,融资额3.34亿人民币,参与投资的机构包括欧普康视,投后估值4.45亿人民币。宿迁市尚悦启程医院管理有限公司成立于2024年,公司主要经营医院管理;卫生用品和一次性使用医疗用品销售;眼镜销售(不含隐形眼镜);第二类医疗器械销售;健康咨询服务(不含诊疗服务);远程健康管理服务。数据来源:天眼查APP以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070800033456.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["CNHmain","CYB","MUCmain","BK0251","MCNHmain","UCmain","300595"],"gpt_icon":0},{"id":"2549758995","title":"欧普康视:与雷神科技、汇鼎光学合作设立合资公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2549758995","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549758995?lang=zh_cn&edition=full","pubTime":"2025-07-07 16:27","pubTimestamp":1751876832,"startTime":"0","endTime":"0","summary":"证券之星消息,欧普康视(300595)07月07日在投资者关系平台上答复投资者关心的问题。投资者提问:请董秘介绍下与雷神科技,汇鼎光学合作的新项目的具体规划及合作内容,以及对未来欧普康视的业绩影响,谢谢!欧普康视回复:您好,三方正在设立合资公司,雷神负责智能眼镜的设计生产,汇鼎提供专用镜片并负责线下销售,欧普康视在体系内销售并参与提升智能眼镜眼健康性能的后续研发工作。公司不便也无法预测此项合作对业绩的影响。敬请广大投资者理性投资,注意风险。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070700021014.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300595","BK0251"],"gpt_icon":0},{"id":"2548286399","title":"【欧普康视:拟3.34亿元收购尚悦启程75%股权】 欧普康视7月4日公告,拟以3.34亿元收购宿迁市尚悦启程医院管理有限公司75%股权,其中拟使用募集资金2.34亿元,自有资金1亿元。本次收购完成后,尚悦启程将成为公司控股子公司并纳入合并财务报表范围。","url":"https://stock-news.laohu8.com/highlight/detail?id=2548286399","media":"金融界","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548286399?lang=zh_cn&edition=full","pubTime":"2025-07-04 21:24","pubTimestamp":1751635490,"startTime":"0","endTime":"0","summary":"欧普康视7月4日公告,拟以3.34亿元收购宿迁市尚悦启程医院管理有限公司75%股权,其中拟使用募集资金2.34亿元,自有资金1亿元。本次收购完成后,尚悦启程将成为公司控股子公司并纳入合并财务报表范围。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/07/04212451499317.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0251","300595"],"gpt_icon":0},{"id":"2548391973","title":"欧普康视:巩膜镜可以矫正视力但无塑形角膜作用","url":"https://stock-news.laohu8.com/highlight/detail?id=2548391973","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548391973?lang=zh_cn&edition=full","pubTime":"2025-07-04 08:46","pubTimestamp":1751589975,"startTime":"0","endTime":"0","summary":"证券之星消息,欧普康视(300595)07月03日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好,关于开展医疗机构验配角膜塑形镜排查整治工作的通知中提到8岁以下严禁佩戴,请问巩膜镜是否可以替代角膜镜的治疗作用?欧普康视回复:您好,巩膜镜可以矫正视力,但没有塑形角膜作用。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070400006257.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300595","BK0251"],"gpt_icon":0},{"id":"2548831956","title":"欧普康视:截止到2025年6月30日股东总人数为63,088户","url":"https://stock-news.laohu8.com/highlight/detail?id=2548831956","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548831956?lang=zh_cn&edition=full","pubTime":"2025-07-02 08:58","pubTimestamp":1751417890,"startTime":"0","endTime":"0","summary":"证券之星消息,欧普康视(300595)07月01日在投资者关系平台上答复投资者关心的问题。投资者提问:截止六月底股东人数?欧普康视回复:您好,截止到2025年6月30日,公司股东总人数为63,088户。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070200006395.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300595"],"gpt_icon":0},{"id":"2548831992","title":"欧普康视:江苏多姿医疗隐形眼镜已开始生产并接到少量订单","url":"https://stock-news.laohu8.com/highlight/detail?id=2548831992","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548831992?lang=zh_cn&edition=full","pubTime":"2025-07-02 08:55","pubTimestamp":1751417713,"startTime":"0","endTime":"0","summary":"证券之星消息,欧普康视(300595)07月01日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好,请问江苏多姿医疗的隐形眼镜是否已经开始对外销售?主要的销售渠道是哪些地方?销售的品牌名是?谢谢!欧普康视回复:您好,江苏多姿医疗的隐形眼镜已开始生产并已接到少量订单,计划7月上旬启动交付。目前隐形眼镜业务模式为OEM,暂无自主品牌。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070200006344.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159891","300595","BK0251"],"gpt_icon":0},{"id":"2546788930","title":"欧普康视(300595)6月20日股东户数6.3万户,较上期减少1.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546788930","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546788930?lang=zh_cn&edition=full","pubTime":"2025-06-26 17:07","pubTimestamp":1750928864,"startTime":"0","endTime":"0","summary":"证券之星消息,近日欧普康视披露,截至2025年6月20日公司股东户数为6.3万户,较6月10日减少945.0户,减幅为1.48%。在医疗器械行业个股中,欧普康视股东户数高于行业平均水平,截至6月20日,医疗器械行业平均股东户数为2.17万户。从股价来看,2025年6月10日至2025年6月20日,欧普康视区间跌幅为4.62%,在此期间股东户数减少945.0户,减幅为1.48%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062600026998.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300595","BK0251"],"gpt_icon":0},{"id":"2546222905","title":"【私募调研记录】祺顺投资调研欧普康视","url":"https://stock-news.laohu8.com/highlight/detail?id=2546222905","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546222905?lang=zh_cn&edition=full","pubTime":"2025-06-26 08:01","pubTimestamp":1750896062,"startTime":"0","endTime":"0","summary":"根据市场公开信息及6月25日披露的机构调研信息,知名私募祺顺投资近期对1家上市公司进行了调研,相关名单如下:1)欧普康视 调研纪要:欧普康视介绍了其新产品如巩膜镜和新一代角膜塑形镜的市场表现及推广计划,强调了社区化视光服务终端的发展策略,并解释了如何应对硬镜产品价格下降的趋势。此外,公司表示将通过并购和战略合作店计划扩展视光终端,平衡规模和服务品质。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2025062600005160.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300595","BK0251"],"gpt_icon":0},{"id":"2546699762","title":"欧普康视:6月24日组织现场参观活动,中信证券、海富投资等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2546699762","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546699762?lang=zh_cn&edition=full","pubTime":"2025-06-25 11:32","pubTimestamp":1750822347,"startTime":"0","endTime":"0","summary":"证券之星消息,2025年6月25日欧普康视发布公告称公司于2025年6月24日组织现场参观活动,中信证券、海富投资、祺顺投资、君和立成、融生创业、北方工业、其他11家机构、个人、平安证券、招商证券、甬兴证券、方正证券、华泰证券、野村国际、巨杉资产、瑞华投资参与。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062500015584.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","LU1997244956.HKD","LU1328615791.USD","300595","LU1997245094.SGD","LU1720050803.USD","LU2289578879.USD","BK1521","06030","BK1516","LU2148510915.USD","LU1064130708.USD","LU1997245177.USD","LU1064131003.USD","LU1655091616.SGD","BK0251","BK0276","LU0405327494.USD","BK1147","LU0405327148.USD","LU2495084118.USD","BK0012","BK0196","BK0028","BK1564","LU1794554557.SGD","600030","BK0183"],"gpt_icon":0},{"id":"2545428423","title":"欧普康视新提交2件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2545428423","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545428423?lang=zh_cn&edition=full","pubTime":"2025-06-24 05:45","pubTimestamp":1750715142,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示,近日欧普康视科技股份有限公司新提交2件商标注册申请。商标申请详情如下:今年以来欧普康视科技股份有限公司新申请注册商标14件,截止目前公司共持有注册商标128件,另有64件商标尚在注册申请中。通过天眼查大数据分析,欧普康视科技股份有限公司共对外投资了116家企业,参与招投标项目176次;财产线索方面有商标信息173条,专利信息98条,著作权信息24条;此外企业还拥有行政许可198个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062400004343.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300595"],"gpt_icon":0},{"id":"2544561914","title":"欧普康视:视光中心由视光技术人员提供专业服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2544561914","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544561914?lang=zh_cn&edition=full","pubTime":"2025-06-18 08:43","pubTimestamp":1750207390,"startTime":"0","endTime":"0","summary":"证券之星消息,欧普康视(300595)06月17日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司的视光中心和传统眼镜店和眼科连锁店有什么区别?欧普康视回复:您好,视光中心由视光技术人员提供专业服务,主业为解决视力矫正和视力健康问题,目前业务内容包括视力矫正和近视防控、视功能训练、干眼和视疲劳理疗、眼健康咨询服务等。眼科诊所则范围更广,可以从事眼病诊疗,甚至手术。眼镜店则以销售眼镜等产品为主。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061800005280.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300595"],"gpt_icon":0},{"id":"2542321588","title":"欧普康视:公司将持续努力推动业务发展做好经营管理","url":"https://stock-news.laohu8.com/highlight/detail?id=2542321588","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542321588?lang=zh_cn&edition=full","pubTime":"2025-06-11 08:58","pubTimestamp":1749603490,"startTime":"0","endTime":"0","summary":"证券之星消息,欧普康视(300595)06月10日在投资者关系平台上答复投资者关心的问题。投资者提问:有没有思考过你们市值管理了五年,市场一直不买账的原因是什么,股价低迷于企业于股民都没好处欧普康视回复:您好,公司将持续努力推动公司业务发展、做好经营管理和研发管理,努力为投资者创造更大的价值,同时进一步加强公司的市值管理工作。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061100004525.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300595","BK0251"],"gpt_icon":0},{"id":"2542132158","title":"欧普康视:巩膜镜和塑形镜出口到海外要先取得当地药械管理部门的许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2542132158","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542132158?lang=zh_cn&edition=full","pubTime":"2025-06-11 08:58","pubTimestamp":1749603488,"startTime":"0","endTime":"0","summary":"证券之星消息,欧普康视(300595)06月10日在投资者关系平台上答复投资者关心的问题。投资者提问:国外是否有公司对贵司生产的最新一代巩膜镜和塑形镜有合作意向?贵司的海外发展之路目前有哪些集体进展?欧普康视回复:您好,巩膜镜和塑形镜属于医疗器械,出口到海外要先取得当地药械管理部门的许可。一些普通的日用眼健康产品已开始通过跨境电商平台销售。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061100004522.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300595","BK0251"],"gpt_icon":0},{"id":"2542359146","title":"欧普康视:已有一些签约,具体数据不便在互动易中披露","url":"https://stock-news.laohu8.com/highlight/detail?id=2542359146","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542359146?lang=zh_cn&edition=full","pubTime":"2025-06-10 08:30","pubTimestamp":1749515439,"startTime":"0","endTime":"0","summary":"证券之星消息,欧普康视(300595)06月09日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司现有加盟店多少间?是否应该加大推广力度?欧普康视回复:您好,刚启动,属于试行阶段,已有一些签约,具体数据不便在互动易中披露。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061000005393.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300595","BK0251"],"gpt_icon":0},{"id":"2541605814","title":"【投融资动态】博视医疗C轮融资,投资方为南京新工投资、欧普康视等","url":"https://stock-news.laohu8.com/highlight/detail?id=2541605814","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541605814?lang=zh_cn&edition=full","pubTime":"2025-06-07 19:18","pubTimestamp":1749295103,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP于6月4日公布的信息整理,南京博视医疗科技有限公司C轮融资,融资额未披露,参与投资的机构包括南京新工投资,欧普康视,泰煜投资。博视医疗是一家眼科医疗器械研发商,公司专注于眼科医疗器械产品的研发,将采用激光、光学成像、人眼跟踪和人工智能技术研发诊断加治疗为一体的智能眼科设备,公司目前研发了超高清眼底成像仪,并进行了临床实验。数据来源:天眼查APP以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060700012491.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159891","300595","BK0251"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753508553808,"stockEarnings":[{"period":"1week","weight":0.1266},{"period":"1month","weight":0.1721},{"period":"3month","weight":0.2397},{"period":"6month","weight":0.0709},{"period":"1year","weight":0.1668},{"period":"ytd","weight":-0.0371}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0398},{"period":"3month","weight":0.0906},{"period":"6month","weight":0.1048},{"period":"1year","weight":0.2449},{"period":"ytd","weight":0.0722}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"欧普康视科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"62918人(较上一季度减少0.41%)","perCapita":"10624股","listingDate":"2017-01-17","address":"安徽省合肥市蜀山区高新区望江西路4899号","registeredCapital":"89615万元","survey":" 欧普康视科技股份有限公司的主营业务是眼视光产品及相关配套产品的研发、生产、销售,以及眼视光服务。公司的主要产品是硬性接触镜类、护理产品、硬镜以外的其它视光产品、其它眼健康产品。","listedPrice":23.81},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"欧普康视(300595)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供欧普康视(300595)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"欧普康视,300595,欧普康视股票,欧普康视股票老虎,欧普康视股票老虎国际,欧普康视行情,欧普康视股票行情,欧普康视股价,欧普康视股市,欧普康视股票价格,欧普康视股票交易,欧普康视股票购买,欧普康视股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"欧普康视(300595)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供欧普康视(300595)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}